Investure Stake in American Express Co (AXP) Has Raised as Stock Declined; Grisanti Capital Management Decreased Its Stake in Pfizer (PFE) as Shares Declined

June 14, 2018 - By Ash

Pfizer Inc. (NYSE:PFE) Logo

Investure Llc increased its stake in American Express Co (AXP) by 95.51% based on its latest 2018Q1 regulatory filing with the SEC. Investure Llc bought 91,275 shares as the company’s stock declined 0.53% with the market. The institutional investor held 186,845 shares of the consumer services company at the end of 2018Q1, valued at $17.43M, up from 95,570 at the end of the previous reported quarter. Investure Llc who had been investing in American Express Co for a number of months, seems to be bullish on the $85.83 billion market cap company. The stock decreased 0.26% or $0.26 during the last trading session, reaching $99.76. About 3.20M shares traded. American Express Company (NYSE:AXP) has risen 30.55% since June 14, 2017 and is uptrending. It has outperformed by 17.98% the S&P500. Some Historical AXP News: 18/04/2018 – American Express Loan Portfolio Rose 16 %; 20/03/2018 – American Express: Elevating Fraud Monitoring for Accounts That Might Have Been Impacted by Orbitz Attack; 20/03/2018 – American Express: Attack Didn’t Compromise American Express Global Business Travel or American Express Platforms; 08/05/2018 – Box Founds Future of Work Council to Bring Together Leaders From Innovative Enterprises Like American Express, NIKE and Farmers; 13/03/2018 – AMERICAN EXPRESS CO – YOUNG IS CHIEF EXECUTIVE OFFICER OF MCAFEE, LLC; 18/04/2018 – American Express Co Closes Above 50-Day Moving Average; 20/03/2018 – AMERICAN EXPRESS STATEMENT REGARDING ORBITZ CYBER ATTACK; 18/04/2018 – American Express 1Q Global Comml Services Net $552M; 13/03/2018 – American Express Elects Christopher D. Young to Bd of Directors; 16/04/2018 – AMERICAN EXPRESS -PRELIMINARY U.S. SMALL BUSINESS CARD MEMBER LOANS 30 DAYS PAST DUE LOANS AS A % OF TOTAL 1.3 PCT AT MARCH END VS 1.4 PCT AT FEB END

Christopher C. Grisanti decreased its stake in Pfizer Inc (PFE) by 13.6% based on its latest 2018Q1 regulatory filing with the SEC. Grisanti Capital Management Llc sold 12,980 shares as the company’s stock declined 3.80% with the market. The hedge fund run by Christopher C. Grisanti held 82,475 shares of the health care company at the end of 2018Q1, valued at $2.93M, down from 95,455 at the end of the previous reported quarter. Grisanti Capital Management Llc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $211.52B market cap company. The stock decreased 0.17% or $0.06 during the last trading session, reaching $36.16. About 18.82 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 10.95% since June 14, 2017 and is uptrending. It has underperformed by 1.62% the S&P500. Some Historical PFE News: 03/04/2018 – PFIZER, P&G FAR APART ON PRICE IN CONSUMER BUSINESS SALE – CNBC, CITING; 02/05/2018 – CDRD and Pfizer Canada Partner to Establish The CDRD Life Sciences Executive Institute; 10/04/2018 – Top 3 today — #1 Pfizer heads to the Hudson, signs 20-year lease at posh new NYC headquarters $PFE @BrittanyMeiling; 16/04/2018 – AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting; 30/05/2018 – TNF Cycling in Psoriatic Arthritis Declines for the Second Year in a Row as Newly Approved Agents Such as Pfizer’s Xeljanz and; 01/05/2018 – Pfizer Sees FY Adj EPS $2.90-Adj EPS $3.00; 23/03/2018 – GLAXOSMITHKLINE PLC GSK.L – CONFIRMS IT HAS WITHDRAWN FROM PROCESS RELATING TO PFIZER’S CONSUMER HEALTHCARE BUSINESS; 08/05/2018 – J&J’s Janssen: Darzalex Is the First Monoclonal Antibody Approved for Newly Diagnosed Patients With Newly Diagnosed Multiple Myeloma; 21/05/2018 – ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV; 07/05/2018 – Roche: FDA Grants Priority Review for Tecentriq in Lung Cancer Treatment

Among 38 analysts covering American Express Company (NYSE:AXP), 13 have Buy rating, 3 Sell and 22 Hold. Therefore 34% are positive. American Express Company had 123 analyst reports since July 23, 2015 according to SRatingsIntel. On Thursday, April 19 the stock rating was maintained by Barclays Capital with “Equal-Weight”. As per Wednesday, August 23, the company rating was maintained by BMO Capital Markets. Stephens upgraded it to “Equal Weight” rating and $82 target in Tuesday, June 20 report. Oppenheimer maintained American Express Company (NYSE:AXP) on Friday, January 22 with “Underperform” rating. RBC Capital Markets maintained the stock with “Sell” rating in Monday, January 8 report. Jefferies maintained the shares of AXP in report on Tuesday, May 30 with “Hold” rating. The stock has “Sell” rating by UBS on Friday, January 22. The company was downgraded on Friday, January 12 by JP Morgan. The stock has “Sell” rating by RBC Capital Markets on Thursday, April 19. The firm has “Neutral” rating given on Wednesday, November 25 by Piper Jaffray.

More important recent American Express Company (NYSE:AXP) news were published by: Benzinga.com which released: “Similar To Uber, eBay Network Effects Offer Big Upside” on June 08, 2018, also Globenewswire.com published article titled: “New Research: Key Drivers of Growth for Global Payments, Patterson-UTI Energy, Celanese, Westlake Chemical, Las …”, Fool.com published: “Better Buy: Berkshire Hathaway vs. American Express” on June 13, 2018. More interesting news about American Express Company (NYSE:AXP) was released by: 247Wallst.com and their article: “American Express Busts Out New Cash Back Card” with publication date: June 14, 2018.

Since January 2, 2018, it had 0 insider purchases, and 8 selling transactions for $12.05 million activity. Shares for $1.27M were sold by Bush James Peter. CAMPBELL JEFFREY C had sold 9,000 shares worth $882,406. 12,500 shares were sold by Squeri Stephen J, worth $1.23 million. Another trade for 3,804 shares valued at $376,710 was made by Buckminster Douglas E. on Wednesday, February 21. Cox L Kevin sold $5.07 million worth of American Express Company (NYSE:AXP) on Thursday, April 19.

Investors sentiment decreased to 0.81 in Q1 2018. Its down 0.08, from 0.89 in 2017Q4. It is negative, as 52 investors sold AXP shares while 462 reduced holdings. 99 funds opened positions while 318 raised stakes. 695.82 million shares or 0.87% less from 701.90 million shares in 2017Q4 were reported. Autus Asset Mgmt Ltd Liability Co owns 4,310 shares for 0.07% of their portfolio. Davenport Co Ltd Co has 44,403 shares for 0% of their portfolio. Montgomery Investment Mgmt Incorporated holds 0.11% in American Express Company (NYSE:AXP) or 2,913 shares. Cadence Capital Lc accumulated 27,710 shares. Boyar Asset Mgmt holds 0.43% of its portfolio in American Express Company (NYSE:AXP) for 6,370 shares. Stock Yards Bankshares Trust reported 4,298 shares. Whitnell stated it has 1,978 shares or 0.08% of all its holdings. Chilton Capital Mgmt Lc has 1.04% invested in American Express Company (NYSE:AXP) for 111,869 shares. Lombard Odier Asset Mgmt (Europe) holds 0.05% or 7,681 shares in its portfolio. Cubic Asset Mngmt Lc accumulated 63,759 shares. City has invested 0.05% in American Express Company (NYSE:AXP). Wealthfront Inc has 31,387 shares. Neville Rodie & Shaw Inc holds 0.81% or 78,330 shares in its portfolio. Commonwealth State Bank Of Australia holds 0.12% or 116,221 shares. 3,075 are owned by Cypress Asset Incorporated Tx.

Among 23 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Pfizer had 80 analyst reports since July 29, 2015 according to SRatingsIntel. SunTrust maintained Pfizer Inc. (NYSE:PFE) rating on Sunday, January 28. SunTrust has “Hold” rating and $40.0 target. The company was maintained on Friday, March 24 by Societe Generale. Morgan Stanley maintained Pfizer Inc. (NYSE:PFE) on Wednesday, January 31 with “Overweight” rating. As per Monday, September 18, the company rating was maintained by Cowen & Co. Argus Research maintained the stock with “Buy” rating in Tuesday, November 3 report. Jefferies maintained the stock with “Buy” rating in Monday, June 20 report. Morgan Stanley upgraded the stock to “Overweight” rating in Friday, October 2 report. The firm has “Overweight” rating by Piper Jaffray given on Saturday, September 5. The rating was maintained by Piper Jaffray with “Buy” on Thursday, September 14. The firm earned “Buy” rating on Monday, August 14 by Cowen & Co.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: 247Wallst.com which released: “Pfizer Drops $600 Million in Its Venture Capital Arm” on June 06, 2018, also Seekingalpha.com with their article: “Pfizer – Still A Hold For The Dividend” published on June 08, 2018, Bizjournals.com published: “In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection” on June 07, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “ViiV Healthcare’s two-drug HIV regimen successful in late-stage studies; Glaxo up 2% premarket” published on June 14, 2018 as well as Seekingalpha.com‘s news article titled: “Many Large US Firms Sell, Hire And Invest More Overseas Than In US And They Have To Think Globally, Not …” with publication date: June 14, 2018.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 7. They expect $0.75 earnings per share, up 11.94% or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.39B for 12.05 P/E if the $0.75 EPS becomes a reality. After $0.77 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.

Since December 15, 2017, it had 0 insider buys, and 13 selling transactions for $18.09 million activity. READ IAN C sold 132,312 shares worth $4.76M. HILL CHARLES H also sold $986,292 worth of Pfizer Inc. (NYSE:PFE) on Wednesday, February 28. MACKENZIE ALEXANDER R sold $249,750 worth of stock. 9,510 shares valued at $353,677 were sold by LUND-JURGENSEN KIRSTEN on Saturday, February 24. Dolsten Mikael had sold 64,587 shares worth $2.39M. 8,000 shares were sold by JOHNSON RADY A, worth $296,560.

Investors sentiment decreased to 0.89 in Q1 2018. Its down 0.17, from 1.06 in 2017Q4. It fall, as 70 investors sold PFE shares while 718 reduced holdings. 104 funds opened positions while 595 raised stakes. 4.01 billion shares or 1.39% less from 4.07 billion shares in 2017Q4 were reported. Moreover, Invest Counsel has 0.38% invested in Pfizer Inc. (NYSE:PFE). North Management has invested 1.02% in Pfizer Inc. (NYSE:PFE). Pekin Singer Strauss Asset Mgmt Il reported 0.44% stake. Salem Inv Counselors has invested 1.16% in Pfizer Inc. (NYSE:PFE). Palouse Cap Incorporated owns 2.76% invested in Pfizer Inc. (NYSE:PFE) for 234,004 shares. Old Mutual Customised Solutions (Proprietary) Limited holds 119,530 shares. Inv Svcs Of America reported 0.05% stake. 199,467 were accumulated by Amica Mutual Co. Tsp Capital Mngmt Ltd Liability Com invested 0.98% of its portfolio in Pfizer Inc. (NYSE:PFE). Howard has invested 0.44% in Pfizer Inc. (NYSE:PFE). 411,882 are held by Ok. Howe And Rusling Incorporated stated it has 2.26% in Pfizer Inc. (NYSE:PFE). The Texas-based South Texas Money Management has invested 0.08% in Pfizer Inc. (NYSE:PFE). Levin Strategies LP holds 7.09 million shares or 4.58% of its portfolio. Spirit Of America Mgmt New York holds 16,900 shares or 0.08% of its portfolio.

Grisanti Capital Management Llc, which manages about $258.00 million and $218.40 million US Long portfolio, upped its stake in Union Pac Corp (NYSE:UNP) by 49,452 shares to 52,652 shares, valued at $7.08 million in 2018Q1, according to the filing. It also increased its holding in Schlumberger Ltd (NYSE:SLB) by 15,604 shares in the quarter, for a total of 79,239 shares, and has risen its stake in Comcast Corp New (NASDAQ:CMCSA).

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>